Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use
申请人:The Regents of the University of California
公开号:US11173146B2
公开(公告)日:2021-11-16
Benzoxazole and indole type KCa3.1 activators as well as the therapeutic uses of such compounds in human or animal subjects and their use in ex vivo preservation of organs or tissues.
SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
申请人:Sørensen Ulrik Svane
公开号:US20120101112A1
公开(公告)日:2012-04-26
This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
SELECTIVE ACTIVATORS OF THE INTERMEDIATE CONDUCTANCE CA2+ACTIVATED K+ CHANNEL KCa3.1 AND THEIR METHODS OF USE
申请人:The Regents of the University of California
公开号:US20170056376A1
公开(公告)日:2017-03-02
Benzoxazole and indole type KCa3.1 activators as well as the therapeutic uses of such compounds in human or animal subjects and their use in ex vivo preservation of organs or tissues.
[EN] SELECTIVE ACTIVATORS OF THE INTERMEDIATE CONDUCTANCE CA2+-ACTIVATED K+ CHANNEL KCA3.1 AND THEIR METHODS OF USE<br/>[FR] ACTIVATEURS SÉLECTIFS DES CANAUX K+ (KCA3.1) ACTIVÉS PAR LE CA2+ À CONDUCTANCE INTERMÉDIAIRE, ET LEURS MÉTHODES D'UTILISATION
申请人:UNIV CALIFORNIA
公开号:WO2015164816A2
公开(公告)日:2015-10-29
Benzoxazole and indole type KCa3.1 activators as well as the therapeutic uses of such compounds in human or animal subjects and their use in ex vivo preservation of organs or tissues.